Updated:
Macromill
CEO 佐々木徹 runs Macromill, a Tokyo-based consumer-intelligence firm whose proprietary panel spans more than 130 million people across 90-plus countries.
Macromill
General information
Firm type
Asset Manager
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Principals
佐々木徹
代表取締役社長 CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Macromill?
Macromill is not an investment firm; it is a marketing-research and data-intelligence company. Strategic and operational decisions rest with CEO 佐々木徹 (Toru Sasaki), who has been the public face of the firm in recent Nikkei and Nikkei Cross Trend interviews. No separate CIO or investment committee appears in the firm's public materials.
How does Macromill source proprietary deal flow?
Macromill does not source investment deal flow. Its competitive advantage lies in sourcing consumer panelists directly, building and maintaining a proprietary network of over 130 million individuals. The firm uses this panel to generate primary research data, not to originate financial transactions.
Is Macromill structured as a single family office or does it operate more like a venture firm?
Macromill is structured as an operating company—a marketing-services and data firm—not a family office or a venture fund. Its revenue comes from selling research services, consumer data, and consulting engagements to enterprise clients. The website references a 'Macromill Group site,' indicating a corporate group structure rather than a pooled investment vehicle.
Does Macromill participate in fund commitments or only direct deals?
There is no public information suggesting Macromill participates in fund commitments or makes direct financial investments. Its business is entirely focused on marketing research, consumer data, and related professional services.
What investment stages does Macromill typically target?
Macromill does not target investment stages. The firm targets stages of the consumer-insight and marketing lifecycle—from product concept testing and clinical evidence gathering through post-launch brand tracking and advertising effectiveness measurement.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: